Gossamer Bio is a San Diego-based clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension. Our goal is to enhance the lives of people living with pulmonary hypertension.
View Top Employees from Gossamer Bio| Website | http://www.gossamerbio.com |
| Ticker | GOSS |
| Revenue | $62.5 million |
| Funding | $120 million |
| Employees | 195 (195 on RocketReach) |
| Founded | 2017 |
| Address | 3013 Science Park Rd Suite 200, San Diego, California 92121, US |
| Phone | (858) 684-1300 |
| Technologies |
JavaScript,
HTML,
PHP
+30 more
(view full list)
|
| Industry | Biotechnology Research, Pharmaceuticals, Biotechnology, Healthcare, Science and Engineering, Health Care, Therapeutics |
| Keywords | Immunology, Oncology, Biotechnology |
| Competitors | Ardelyx, Inc., NGM Biopharmaceuticals, Pliant Therapeutics, Puma Biotechnology, Inc., Reata Pharmaceuticals, Inc. |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 42 Companies, NAICS Code 5417 Companies, NAICS Code 42421 Companies, NAICS Code 54171 Companies, NAICS Code 541 Companies, NAICS Code 541711 Companies, NAICS Code 424 Companies, NAICS Code 4242 Companies, NAICS Code 54 Companies |
Looking for a particular Gossamer Bio employee's phone or email?
Gossamer Bio Questions
The Gossamer Bio annual revenue was $62.5 million in 2024.
Judith Jill Sosa is the Vice President Clinical Operations of Gossamer Bio.
195 people are employed at Gossamer Bio.
Gossamer Bio is based in San Diego, California.
The NAICS codes for Gossamer Bio are [42, 5417, 42421, 54171, 541, 541711, 424, 4242, 54].
The SIC codes for Gossamer Bio are [283, 28].
Top Gossamer Bio Employees
-
35+
-
35
-
55+
-
45+
-
15
-
31
-
25+
-
23
Related Companies
